This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Ultragenyx Pharmaceutical Inc.
Drug Names(s): Recombinant Human Beta-Glucuronidase, rhGUS
Description: UX003 is a recombinant human Beta-glucuronidase intended as an enzyme replacement therapy for the treatment of Mucopolysaccharidosis VII.
Additional information available to subscribers only: